Summit X’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Summit X's GSK Position: Q4 2017 in Review
Summit X sold out of GSK (GSK) in Q4 2017, closing a stake of 10,022 shares — an estimated $506K sold.
Summit X first reported a position in GSK in Q2 2017 and held it in 2 quarters. The position peaked at $665K in Q2 2017. 764 funds tracked by Wall St. Rank hold GSK as of Q4 2017.
- Summit X reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
- Summit X sold 10,022 GSK shares in Q4 2017, an estimated $506K.
- Summit X first reported a position in GSK in Q2 2017 and held it in 2 quarters.
- Summit X's GSK position peaked at $665K in Q2 2017.
- 764 funds tracked by Wall St. Rank held GSK as of Q4 2017.
Based on Summit X's 13F filing for Q4 2017, filed 23 Jan 2018.